ME 23andMe Holding Co Net earnings per share growth forecast for next year

23andMe Inc. - graphic logo of issuer ME

Management crises and conflicts with leadership are weighing on quotes, while the projected net profit growth for 23andMe Holding Co. (ME) demonstrates a level of 0.00, capturing current expectations. Diversification through the development of DNA-data-based drugs mitigates risks, yet the mass exodus of leading bioinformaticians and staff reductions threaten the business's survival. This chart helps track the institutional development trends of 23andMe Holding Co. (ME).

ME: 23andMe Inc. Projected earnings per share growth rate for next year 07/04/2022 - 04/05/2025

Metric breakdowns and analytics for 23andMe Inc. (ME)

- share price and consensus valuation forecast:
- market capitalization data:
Fundamental company valuation:23andMe Holding Co., ME
Finished products of 23andMe Holding Co

Investors must evaluate the competitiveness of 23andMe Holding Co. (ME) through the lens of ESG standard implementation efficiency and genetic data protection. This forward-looking earnings per share growth forecast reflects the consensus estimate of future profitability, enabling a timely identification of business model corrections and preventing the purchase of an overvalued asset amid shifting macroeconomic lags.

Competitor analysis for 23andMe Holding Co.

A (agilent.com) - Earnings growth forecast for next year|DGX - Net earnings per one share growth forecast for next year|Earnings growth forecast for next year ILMN|EXAS - Expected net earnings per share growth next year|Earnings growth forecast for next year RVTY (revvity.com)|Bio-Rad Laboratories (BIO) - Expected net earnings per share growth next year|Anbio Biotechnology - Earnings growth forecast for next year|Expected net earnings per share growth next year soterahealth.com|QDEL: Earnings growth forecast for next year|OPKO Health - Expected earnings per share trend next year|CDNA (CareDx, Inc) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year MRVI|Net earnings per share growth forecast for next year Fulgent Genetics (FLGT)|LAB (Standard BioTools Inc.) - Expected earnings per share trend next year|Earnings growth forecast for next year CTKB (Cytek Biosciences)|OraSure Technologies Inc (OSUR) - Expected net earnings per share growth next year|XGN - Net earnings per share growth forecast for next year|MDxHealth Inc. - Projected earnings per share increase next year|LUCD: Earnings growth forecast for next year|Prenetics Global Limited - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Insight Molecular Diagnostics, Inc.|trinitybiotech.com (TRIB) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year PRPH|Earnings growth forecast for next year Ainos Corp (AIMD)|Earnings growth forecast for next year CODX (codiagnostics.com)|Heart Test Laboratories - Net earnings per share growth forecast for next year|Biomerica Inc. - Earnings growth forecast for next year|Expected net earnings per share growth next year Cardio Diagnostics Holdings|ONCO (Onconetix Corporation) - Expected earnings per share growth for next year|Virax Biolabs Group Ltd - Expected earnings per share trend next year|Net earnings per share growth forecast for next year bluejaydx.com|Expected net earnings per share growth next year Aspira Women's Health AWH|Net earnings per share growth forecast for next year Accelerate Diagnostics, Inc (AXDX)|centogene.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year ENZ (Enzo Biochem)|FRES - Expected earnings per share growth for next year|Genetic Technologies Ltd - Earnings growth forecast for next year|PMD - Earnings growth forecast for next year